These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2791338)

  • 21. Discordant thymectomy in identical twins concordant for myasthenia gravis.
    Riggs KR; Gutmann L; Riggs JE
    Ann Intern Med; 2011 Oct; 155(7):478-9. PubMed ID: 21969350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells.
    Homma M; Uzawa A; Tanaka H; Kawaguchi N; Kanai T; Nakajima K; Narita M; Hara Y; Maruyama H; Ogawa Y; Himuro K; Kuwabara S
    Neurotherapeutics; 2017 Jan; 14(1):191-198. PubMed ID: 27677608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
    Kuwana M; Feghali CA; Medsger TA; Wright TM
    Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man.
    Garchon HJ
    J Autoimmun; 2003 Sep; 21(2):105-10. PubMed ID: 12935778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholine receptor antibodies and anti-idiotypic antibodies produced in blood lymphocyte cultures from patients with myasthenia gravis.
    Lefvert AK; Sundén H; Holm G
    Scand J Immunol; 1986 Jun; 23(6):655-62. PubMed ID: 3715409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia gravis occurring in twins.
    Namba T; Shapiro MS; Brunner NG; Grob D
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):531-4. PubMed ID: 5122380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis.
    Lefvert AK; Pirskanen R; Svanborg E
    J Neuroimmunol; 1985 Jul; 9(1-2):41-53. PubMed ID: 4008636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy.
    Grinlinton FM; Lynch NM; Hart HH
    Arthritis Rheum; 1991 Jul; 34(7):916-9. PubMed ID: 2059238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repertoire cloning of lupus anti-DNA autoantibodies.
    Roben P; Barbas SM; Sandoval L; Lecerf JM; Stollar BD; Solomon A; Silverman GJ
    J Clin Invest; 1996 Dec; 98(12):2827-37. PubMed ID: 8981931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular production of antibodies related to the acetylcholine receptor in myasthenia gravis: correlation with clinical stage.
    Lefvert AK; Holm G; Sundén H; Pirskanen R
    Scand J Immunol; 1987 Mar; 25(3):265-73. PubMed ID: 2436288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against the acetylcholine receptor also in nonmyasthenic autoimmune disease.
    Sundewall AC; Lefvert K
    Ann N Y Acad Sci; 1988; 540():525-7. PubMed ID: 3207283
    [No Abstract]   [Full Text] [Related]  

  • 34. T cells with specificity for idiotypic determinants on human monoclonal autoantibodies in myasthenia gravis.
    Yi Q; Ahlberg R; Lefvert AK
    Res Immunol; 1992 Feb; 143(2):149-56. PubMed ID: 1574640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial occurrence of autoimmune myasthenia gravis with different antibody specificity.
    Lavrnic D; Nikolic A; De Baets M; Verschuuren J; Verduyn W; Losen M; Stojanovic V; Stevic Z; Hajdukovic Lj; Apostolski S
    Neurology; 2008 May; 70(21):2011-3. PubMed ID: 18490624
    [No Abstract]   [Full Text] [Related]  

  • 36. Myasthenia gravis in monozygotic twins. Clinical follow-up nine years after thymectomy.
    Allen N; Kissel P; Pietrasiuk D; Perlow MJ
    Arch Neurol; 1984 Sep; 41(9):994-6. PubMed ID: 6541031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for the treatment of myasthenia gravis.
    Drachman DB; McIntosh KR; De Silva S; Kuncl RW; Kahn C
    Ann N Y Acad Sci; 1988; 540():176-86. PubMed ID: 2849890
    [No Abstract]   [Full Text] [Related]  

  • 38. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The auto-anti-idiotypic route to antireceptor antibodies.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS
    Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.